NCT00411268View on ClinicalTrials.gov

Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2001

Conditions
Low Back Pain
Interventions
DRUG

OROS hydromorphone HCI SR (slow release)

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00411268 - Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain | Biotech Hunter | Biotech Hunter